Glaukos (GKOS) Earnings, Outlook ‘Brighter’; Shares Soar to All-Time High
Published . Updated .
Glaukos Corp. (NYSE:GKOS)—an ophthalmic medical technology and pharmaceutical company—soared to a new all-time high on Thursday amid positive catalysts, including strong earnings, a higher growth outlook, and bullish analyst comments. In intra-day trading, the stock surged to
Directly affected
- GKOS Glaukos+6.0% 11d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Glaukos belongs to, so it often moves with news about it.
- SYK Stryker+8.6% 30d
Stryker is a peer of Glaukos in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+1.5% 30d
3M is a peer of Glaukos in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific-2.7% 30d
Boston Scientific is a peer of Glaukos in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+9.7% 30d
Becton, Dickinson and is a peer of Glaukos in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-11.5% 10d
Medline is a peer of Glaukos in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GKOS | -26.19% | -25.22% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| SYKNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BSXNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Glaukos (GKOS) Earnings, Outlook ‘Brighter’; Shares Soar to All-Time High Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| GKOS | three days earlier | -25.22% | final price |
| GKOS | five days earlier | -26.19% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 51 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 56 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Glaukos (GKOS) Earnings, Outlook ‘Brighter’; Shares Soar to All-Time High” scores 12 out of 100. The score uses 1 sources.